Skip to content
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us

Monthly Sales-2026.06

 

Item Net Revenue
2026.06 893,588
2025.06 769,868
MoM Change 123,720
MoM Change (%) 16.07
2026 1-6 4,728,836
2025 1-6 4,314,285
YoY Change 414,551
YoY Change (%) 9.61
Note The increase in the current month’s revenue and year-to-date revenue was primarily attributable to the inclusion of ASIA BEST LIFE CARE CO., LTD and its subsidiaries in the consolidated entities effective June 2026, which increased revenue by NT$75,476 thousand.

 

PrevPREVIOUSAnnouncement of the resolution by the BOD for the ex-rights and record date of stock dividends on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
NEXTThe 2026 Annual Shareholders’ Meeting passes to release the prohibition on directors from participation in competition businesses.Next

Investors

Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us
  • 17F., No. 880, Zhongzheng Rd., Zhonghe Dist., New Taipei City, Taiwan
  • +886-2-2225-1888
[raiseup_copyright]